Study of the Antiviral Mechanism of Cytovir®-3 Against Respiratory Viruses In Vitro
- 30 October 2025
- journal article
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 70 (9-10)
Abstract
Background. Modern clinical practice often excludes the possibility of differential diagnostics for acute respiratory viral infection pathogens and identification of a specific viral pathogen. In this regard, it is important to search for drugs with a broad spectrum of activity against pathogens of acute respiratory viral infections. The aim of the study was to assess the antiviral activity of the drug Cytovir®-3 in vitro against the cytopathogenic effect of human adenovirus. Material and methods. The antiviral effect of the drug Cytovir®-3 in comparison with the drug Umifenovir against human adenovirus type 5 was studied on Vero cell culture. The drugs were administered 1 hour before (prophylactic regimen) and 1 hour after (therapeutic regimen) infection of the cell culture with the virus. The working concentration range for the studied drugs was determined based on the 50% cytotoxic concentration values, calculated based on the results of the microtetrazolium (MTT) assay. Results and discussion . The drug Cytovir®-3 in two application regimens (therapeutic or prophylactic) demonstrated antiviral efficacy in vitro against human adenovirus in the non-toxic range (0-631 µg/ml) regardless of the application scheme (therapeutic or prophylactic ). Conclusion . The in vitro antiviral activity of the drug Cytovir®-3 against human adenovirus has been proven. Moreover, in all series of experiments, Cytovir®-3 had a selectivity index comparable to that of the reference drug Umifenovir.Keywords
This publication has 43 references indexed in Scilit:
- Human adenovirus (HAdV) infection in children with acute respiratory tract infections in Guangzhou, China, 2010–2021: a molecular epidemiology studyWorld Journal of Pediatrics, 2022
- Human adenovirus infections in pediatric population - An update on clinico–pathologic correlationBiomedical Journal, 2021
- Treatment of respiratory virus infectionsAntiviral Research, 2006
- Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999–2004☆Vaccine, 2006
- The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitisOphthalmology, 2002
- The inhibitory effect of the imidazoquinolinamine S-28828 on the pathogenesis of a type II adenovirus in turkeysAntiviral Research, 2000
- Intravenous ribavirin therapy for adenovirus pneumoniaPediatric Pulmonology, 1999
- Cidofovir1999
- Adenovirus inhibition of cellular protein synthesis and the specific translation of late viral mRNAsSeminars in Virology, 1993
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983